Pregnancy category X. Use of Rosuvastatin is contraindicated in pregnancy. If treatment of dyslipidemias is needed in pregnant women or in women of reproductive age, other agents are preferred.
Rosuvastatin is excreted in breast milk (limited data). Due to the potential for serious adverse reactions in a nursing infant, use while breast-feeding is contraindicated by the manufacturer.